Singapore markets open in 2 hours 34 minutes
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,131.84 -2,264.65 (-3.41%) CMC Crypto 200
1,389.76 -34.34 (-2.41%)
GILD Jan 2025 105.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:00PM EDT. Market open.
| Previous close | 0.1800 |
| Open | 0.2200 |
| Bid | 0.0200 |
| Ask | 0.3300 |
| Strike | 105.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.1800 - 0.2200 |
| Contract range | N/A |
| Volume | |
| Open interest | 672 |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.